Seaport Therapeutics CEO Zohar Daphne transfers 100,000 shares to a donor-advised fund, impacting company leadership and industry dynamics.
| Name | Seaport Therapeutics, Inc. |
|---|---|
| CIK | 0002042347 |
| Tickers | SPTX |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 992235719 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | 617-807-4062 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Seaport Therapeutics CEO Zohar Daphne transfers 100,000 shares to a donor-advised fund, impacting company leadership and industry dynamics.
Seaport Therapeutics' director Denice Torres acquires 5,000 shares, reflecting confidence in the company's future within the pharmaceutical preparations sector.
Seaport Therapeutics, Inc. releases its Q3 financial results, showcasing strategic developments in the pharmaceutical preparations sector.
Seaport Therapeutics, Inc. announces its financial results for Q3 2026, impacting the pharmaceutical preparations industry and influencing stakeholder decisions.
59 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-13 | 4 | 4 | 0001193125-26-459372 | 4766 | ||||||
| 2026-11-04 | 4 | 4 | 0001193125-26-446216 | 5588 | ||||||
| 2026-11-02 | 10-Q | 10-Q | 0001193125-26-442634 | 001-43254 | 261509877 | 34 | 11770839 | 1 | 1 | |
| 2026-11-02 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-442625 | 001-43254 | 261509865 | 34 | 339661 | 1 | 1 |
| 2026-08-14 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001193125-26-352401 | 005-95656 | 261282455 | 34 | 126107 | |||
| 2026-08-05 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001193125-26-333914 | 005-95656 | 261241415 | 34 | 6649 | |||
| 2026-08-05 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001193125-26-333719 | 005-95656 | 261241101 | 34 | 6663 | |||
| 2026-08-03 | 10-Q | 10-Q | 0001193125-26-329537 | 001-43254 | 261230446 | 34 | 11288792 | 1 | 1 | |
| 2026-08-03 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-329528 | 001-43254 | 261230434 | 34 | 335394 | 1 | 1 |
| 2026-06-24 | 4 | 4 | 0001193125-26-280175 | 5583 | ||||||
| 2026-06-08 | 10-Q | 10-Q | 0001193125-26-260678 | 001-43254 | 261071017 | 34 | 9734007 | 1 | 1 | |
| 2026-06-08 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-260671 | 001-43254 | 261071009 | 34 | 323749 | 1 | 1 |
| 2026-05-11 | SCHEDULE 13D | xslSCHEDULE_13D_X02/primary_doc.xml | 0000950142-26-001350 | 005-95656 | 26965165 | 34 | 126723 | |||
| 2026-05-11 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000886982-26-000211 | 005-95656 | 26962650 | 34 | 17855 | |||
| 2026-05-06 | 3 | OWNERSHIP DOCUMENT | 0000950142-26-001309 | 12268 | ||||||
| 2026-05-06 | 3 | OWNERSHIP DOCUMENT | 0000950142-26-001308 | 24291 | ||||||
| 2026-05-06 | 4 | 4 | 0001193125-26-209701 | 17259 | ||||||
| 2026-05-06 | SCHEDULE 13D | xslSCHEDULE_13D_X02/primary_doc.xml | 0001193125-26-209100 | 005-95656 | 26948910 | 34 | 135676 | |||
| 2026-05-04 | 4 | 4 | 0001193125-26-204507 | 7452 | ||||||
| 2026-05-04 | 4 | 4 | 0001193125-26-204494 | 11915 | ||||||
| 2026-05-04 | 4 | 4 | 0001193125-26-204493 | 10032 | ||||||
| 2026-05-04 | 4 | 4 | 0001193125-26-204484 | 5339 | ||||||
| 2026-05-04 | 4 | 4 | 0001193125-26-204483 | 5275 | ||||||
| 2026-05-04 | 4 | 4 | 0001193125-26-204479 | 9238 | ||||||
| 2026-05-04 | 4 | 4 | 0001193125-26-204471 | 9255 | ||||||
| 2026-05-04 | 4 | 4 | 0001193125-26-204468 | 9845 | ||||||
| 2026-05-04 | 4 | 4 | 0001193125-26-204465 | 11147 | ||||||
| 2026-05-04 | 4 | 4 | 0001193125-26-204458 | 23408 | ||||||
| 2026-05-04 | 4 | 4 | 0001193125-26-204456 | 5319 | ||||||
| 2026-05-04 | 4 | 4 | 0001193125-26-204452 | 9213 | ||||||
| 2026-05-04 | 4 | 4 | 0001193125-26-204449 | 5424 | ||||||
| 2026-05-04 | 8-K | 8-K | 5.03,9.01 | 0001193125-26-204086 | 001-43254 | 26938140 | 34 | 362703 | 1 | 1 |
| 2026-05-04 | S-8 | S-8 | 0001193125-26-201834 | 333-295514 | 26934107 | 33 | 237866 | 1 | 1 | |
| 2026-05-01 | 424B4 | 424B4 | 0001193125-26-201758 | 333-294976 | 26933946 | 33 | 5246610 | |||
| 2026-04-30 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-001408 | 333-294976 | 26928619 | 33 | 1743 | ||
| 2026-04-30 | 3 | 3 | 0001193125-26-198652 | 10230 | ||||||
| 2026-04-30 | 3 | 3 | 0001193125-26-198532 | 18736 | ||||||
| 2026-04-30 | 3 | 3 | 0001193125-26-198531 | 20930 | ||||||
| 2026-04-30 | 3 | 3 | 0001193125-26-198524 | 15577 | ||||||
| 2026-04-30 | 3 | 3 | 0001193125-26-198523 | 19529 | ||||||
| 2026-04-30 | 3 | 3 | 0001193125-26-198522 | 19589 | ||||||
| 2026-04-30 | 3 | 3 | 0001193125-26-198514 | 15348 | ||||||
| 2026-04-30 | 3 | 3 | 0001193125-26-198510 | 18208 | ||||||
| 2026-04-30 | 3 | 3 | 0001193125-26-198509 | 19032 | ||||||
| 2026-04-30 | 3 | 3 | 0001193125-26-198507 | 21215 | ||||||
| 2026-04-30 | 3 | 3 | 0001193125-26-198505 | 16748 | ||||||
| 2026-04-30 | 3 | 3 | 0001193125-26-198501 | 21873 | ||||||
| 2026-04-30 | 3 | 3 | 0001193125-26-198492 | 22028 | ||||||
| 2026-04-30 | 3 | 3 | 0001193125-26-198491 | 17613 | ||||||
| 2026-04-30 | 3 | 3 | 0001193125-26-198489 | 22008 | ||||||
| 2026-04-30 | S-1MEF | S-1MEF | 0001193125-26-198107 | 333-295477 | 26927831 | 33 | 188522 | 1 | 1 | |
| 2026-04-30 | CERT | SPTX_8A_Cert_2042347.pdf | 0001354457-26-000398 | 001-43254 | 26925620 | 34 | 563757 | |||
| 2026-04-28 | 8-A12B | 8-A12B | 0001193125-26-186943 | 001-43254 | 26907618 | 34 | 15533 | |||
| 2026-04-27 | S-1/A | S-1/A | 0001193125-26-178716 | 333-294976 | 26896383 | 33 | 6238654 | 1 | 1 | |
| 2026-04-10 | S-1 | S-1 | 0001193125-26-151211 | 333-294976 | 26854768 | 33 | 7985085 | 1 | 1 | |
| 2026-02-27 | DRS/A | filename1.htm | 0001193125-26-083019 | 377-08713 | 26701118 | 33 | 5276153 | |||
| 2026-01-29 | DRS/A | filename1.htm | 0001193125-26-027903 | 377-08713 | 26574417 | 33 | 5504829 | |||
| 2025-11-21 | DRS | filename1.htm | 0001193125-25-290911 | 377-08713 | 251505676 | 33 | 4935143 | |||
| 2024-10-31 | D | xslFormDX01/primary_doc.xml | 06b | 0002042347-24-000001 | 021-528276 | 241412430 | 33 | 15572 |
One latest value per concept from companyfacts (137 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 53.53M | 2026-10-27 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| ffd | NetFeeAmt | NetFeeAmt | USD | 22,764.93 | 2026-05-01 | S-8 | 2026-05-04 | 0001193125-26-201834 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 22,764.93 | 2026-05-01 | S-8 | 2026-05-04 | 0001193125-26-201834 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 164.84M | 2026-05-01 | S-8 | 2026-05-04 | 0001193125-26-201834 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-05-01 | S-8 | 2026-05-04 | 0001193125-26-201834 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 0 | 2026-04-30 | S-1MEF | 2026-04-30 | 0001193125-26-198107 | |||
| us-gaap | AccountsPayableAndOtherAccruedLiabilitiesCurrent | Accounts Payable and Other Accrued Liabilities, Current | USD | 9.67M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 5.81M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | AccruedBonusesCurrent | Accrued Bonuses, Current | USD | 4.25M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | AccruedLiabilitiesCurrentAndNoncurrent | Accrued Liabilities | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 1.07M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -1.68M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 627.64M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 36.86M | 2026-04-01 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 41.88M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 |
| us-gaap | AmortizationOfFinancingCostsAndDiscounts | Amortization of Debt Issuance Costs and Discounts | USD | -1.13M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 12.30M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 |
| us-gaap | Assets | Assets | USD | 417.62M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 299.06M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | USD | 2.03M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | AvailableForSaleDebtSecuritiesAmortizedCostBasis | Debt Securities, Available-for-sale, Amortized Cost | USD | 359.28M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 357.25M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 61.55M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 62.01M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | 62.01M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | 15.51M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 |
| us-gaap | CommonStockDividendsPerShareCashPaid | Common Stock, Dividends, Per Share, Cash Paid | USD/shares | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 |
| us-gaap | CommonStockDividendsPerShareDeclared | Common Stock, Dividends, Per Share, Declared | USD/shares | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 700.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 53.53M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 53.53M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 5,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -116.38M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPosition | Debt Securities, Available-for-sale, Unrealized Loss Position | USD | 2.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | DeferredOfferingCosts | Deferred Offering Costs | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | Depreciation | Depreciation | USD | 79,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -3.72 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -3.72 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | -0.008 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 |
| us-gaap | EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | -4,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 |
| us-gaap | FinancialLiabilitiesFairValueDisclosure | Financial Liabilities Fair Value Disclosure | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 53.76M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -113.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 |
| us-gaap | IncomeTaxesPaidNet | Income Taxes Paid, Net | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 898,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 |
| us-gaap | IncreaseDecreaseInAccountsPayableTrade | Increase (Decrease) in Accounts Payable, Trade | USD | 3.80M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 |
| us-gaap | IncreaseDecreaseInDueToRelatedPartiesCurrent | Increase (Decrease) in Due to Related Parties, Current | USD | -7,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 |
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | -982,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 |
| us-gaap | IncreaseDecreaseInOtherNoncurrentAssets | Increase (Decrease) in Other Noncurrent Assets | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 |
| us-gaap | InterestAndOtherIncome | Interest and Other Income | USD | 9.29M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 |
| us-gaap | InterestIncomeExpenseNonoperatingNet | Interest Income (Expense), Nonoperating, Net | USD | 9.29M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 |
| us-gaap | InvestmentsAndCash | Investments and Cash | USD | 403.80M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | Liabilities | Liabilities | USD | 20.17M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 417.62M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 17.11M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | LongTermInvestments | Long-term Investments | USD | 113.36M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 240.05M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | -155.54M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -69.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -114.40M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | 10.19M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 123.69M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -123.69M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 1.62M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 3.06M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 4.41M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | OperatingLeaseRightOfUseAssetAmortizationExpense | Operating Lease, Right-of-Use Asset, Amortization Expense | USD | 987,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 680,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 454,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent | USD | 56,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 |
| us-gaap | OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax | USD | -2.03M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 |
| us-gaap | OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax | USD | 23,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 |
| us-gaap | OtherGeneralAndAdministrativeExpense | Other General and Administrative Expense | USD | 7.62M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 |
| us-gaap | OtherLiabilitiesCurrent | Other Liabilities, Current | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | OtherNonoperatingExpense | Other Nonoperating Expense | USD | 80,000 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-03 | 0001193125-26-329537 |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | -67,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 |
| us-gaap | OtherPrepaidExpenseCurrent | Other Prepaid Expense, Current | USD | 1.79M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | PaymentsToAcquireInvestments | Payments to Acquire Investments | USD | 325.54M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 |
| us-gaap | PreferredStockConvertibleSharesIssuable | PreferredStockConvertibleSharesIssuable | shares | 36.27M | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 10.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 8.63M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | PrepaidInterest | Prepaid Interest | USD | 2.40M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities | Proceeds from Maturities, Prepayments and Calls of Held-to-maturity Securities | USD | 170.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 807,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -114.40M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 1.40M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 333,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 69.94M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 |
| us-gaap | RestrictedCashAndCashEquivalents | Restricted Cash and Cash Equivalents | USD | 454,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -228.51M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 584,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 |
| us-gaap | SecurityDeposit | Security Deposit | USD | 200,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum | pure | 0.945 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum | pure | 0.903 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum | pure | 0.046 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum | pure | 0.036 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 147.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 8.93M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 8.4 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 1.42M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | shares | 392,741 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 4.34M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 199.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 12.30M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 8.68 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | USD | 199.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | shares | 12.30M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | USD/shares | 8.68 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 3.74 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | USD/shares | 5.87 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 16.23 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 |
| us-gaap | ShortTermInvestments | Short-term Investments | USD | 228.88M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 397.45M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio1 | Stockholders' Equity Note, Stock Split, Conversion Ratio | pure | 0.318 | 2026-04-24 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 216,075 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfUnits | Stock Issued During Period, Value, Conversion of Units | USD | 325.33M | 2026-04-01 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 238.36M | 2026-04-01 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 2.45M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 |
| us-gaap | TemporaryEquityCarryingAmountAttributableToParent | Temporary Equity, Carrying Amount, Attributable to Parent | USD | 325.33M | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | TemporaryEquityLiquidationPreference | Temporary Equity, Liquidation Preference | USD | 330.10M | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | TemporaryEquitySharesAuthorized | Temporary Equity, Shares Authorized | shares | 113.92M | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | TemporaryEquitySharesIssued | Temporary Equity, Shares Issued | shares | 113.92M | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | TemporaryEquitySharesOutstanding | Temporary Equity, Shares Outstanding | shares | 113.92M | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 | |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 30.71M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 30.71M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001193125-26-442634 |